0001666071-24-000057.txt : 20240402
0001666071-24-000057.hdr.sgml : 20240402
20240402202242
ACCESSION NUMBER: 0001666071-24-000057
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240401
FILED AS OF DATE: 20240402
DATE AS OF CHANGE: 20240402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Temsamani Karim Saad
CENTRAL INDEX KEY: 0001944491
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38386
FILM NUMBER: 24816530
MAIL ADDRESS:
STREET 1: C/O CARDLYTICS, INC.
STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardlytics, Inc.
CENTRAL INDEX KEY: 0001666071
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
ORGANIZATION NAME: 06 Technology
IRS NUMBER: 263039436
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 4100
CITY: ATLANTA
STATE: GA
ZIP: 30308
BUSINESS PHONE: 888-798-5802
MAIL ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 4100
CITY: ATLANTA
STATE: GA
ZIP: 30308
4
1
wk-form4_1712103752.xml
FORM 4
X0508
4
2024-04-01
0
0001666071
Cardlytics, Inc.
CDLX
0001944491
Temsamani Karim Saad
675 PONCE DE LEON AVE. NE
SUITE 4100
ATLANTA
GA
30308
1
1
0
0
Chief Executive Officer
0
Common Stock
2024-04-01
4
M
0
50000
A
377298
D
Common Stock
2024-04-02
4
S
0
32564
13.69
D
344734
D
Common Stock
2024-04-01
4
S
0
154
14.41
D
344580
D
Restricted Stock Unit
2024-04-01
4
M
0
50000
0
D
Common Stock
50000
0
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.
Shares were sold solely to satisfy withholding tax obligations that resulted from the delivery of shares of common stock for RSUs that vested on April 1, 2024. The Reporting Person did not sell shares for any other purpose.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.40 to $14.375, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) and (4).
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $14.40 to $14.41, inclusive.
This RSU award was originally for 200,000 shares. 25% of the RSU award vested on each of July 1, 2023, October 1, 2023 and January 1, 2024 and April 1, 2024.
/s/ Nick Lynton, Attorney-in-Fact
2024-04-02